Cargando…
Critical COVID-19 disease, homeostasis, and the “surprise” of effective glucocorticoid therapy
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832484/ https://www.ncbi.nlm.nih.gov/pubmed/32745524 http://dx.doi.org/10.1016/j.clim.2020.108550 |
| _version_ | 1783641846848684032 |
|---|---|
| author | Chrousos, George P. Meduri, G.Umberto |
| author_facet | Chrousos, George P. Meduri, G.Umberto |
| author_sort | Chrousos, George P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7832484 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78324842021-01-26 Critical COVID-19 disease, homeostasis, and the “surprise” of effective glucocorticoid therapy Chrousos, George P. Meduri, G.Umberto Clin Immunol Commentary Elsevier Inc. 2020-10 2020-07-31 /pmc/articles/PMC7832484/ /pubmed/32745524 http://dx.doi.org/10.1016/j.clim.2020.108550 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Commentary Chrousos, George P. Meduri, G.Umberto Critical COVID-19 disease, homeostasis, and the “surprise” of effective glucocorticoid therapy |
| title | Critical COVID-19 disease, homeostasis, and the “surprise” of effective glucocorticoid therapy |
| title_full | Critical COVID-19 disease, homeostasis, and the “surprise” of effective glucocorticoid therapy |
| title_fullStr | Critical COVID-19 disease, homeostasis, and the “surprise” of effective glucocorticoid therapy |
| title_full_unstemmed | Critical COVID-19 disease, homeostasis, and the “surprise” of effective glucocorticoid therapy |
| title_short | Critical COVID-19 disease, homeostasis, and the “surprise” of effective glucocorticoid therapy |
| title_sort | critical covid-19 disease, homeostasis, and the “surprise” of effective glucocorticoid therapy |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832484/ https://www.ncbi.nlm.nih.gov/pubmed/32745524 http://dx.doi.org/10.1016/j.clim.2020.108550 |
| work_keys_str_mv | AT chrousosgeorgep criticalcovid19diseasehomeostasisandthesurpriseofeffectiveglucocorticoidtherapy AT medurigumberto criticalcovid19diseasehomeostasisandthesurpriseofeffectiveglucocorticoidtherapy |